Pramiset 0.125 Tablet contains Pramipexole 0.125mg, a dopamine agonist commonly prescribed for the management of Parkinson’s disease and Restless Leg Syndrome (RLS). It helps compensate for dopamine deficiency in the brain, improving motor control, reducing tremors, stiffness, and improving movement coordination.
This medicine belongs to the Neurology and CNS segment, making it a widely prescribed product by neurologists and movement disorder specialists. Pramipexole is known for its role in early-stage Parkinson’s treatment and as an add-on therapy in advanced stages.
Due to long-term chronic treatment requirements, this product ensures high repeat demand, making it a profitable choice for PCD pharma franchise holders, wholesalers, and hospital suppliers.
Pramiset 0.125 Tablet is available for:
This product is a strong addition to any neurology portfolio with steady market demand and long-term prescription sustainability.